System-based identification of toxicity pathways associated with multi-walled carbon nanotube-induced pathological responses.

The fibrous shape and biopersistence of multi-walled carbon nanotubes (MWCNT) have raised concern over their potential toxicity after pulmonary exposure. As in vivo exposure to MWCNT produced a transient inflammatory and progressive fibrotic response, this study sought to identify significant biological processes associated with lung inflammation and fibrosis pathology data, based upon whole genome mRNA expression, bronchoaveolar lavage scores, and morphometric analysis from C57BL/6J mice exposed by pharyngeal aspiration to 0, 10, 20, 40, or 80 μg MWCNT at 1, 7, 28, or 56 days post-exposure. Using a novel computational model employing non-negative matrix factorization and Monte Carlo Markov Chain simulation, significant biological processes with expression similar to MWCNT-induced lung inflammation and fibrosis pathology data in mice were identified. A subset of genes in these processes was determined to be functionally related to either fibrosis or inflammation by Ingenuity Pathway Analysis and was used to determine potential significant signaling cascades. Two genes determined to be functionally related to inflammation and fibrosis, vascular endothelial growth factor A (vegfa) and C-C motif chemokine 2 (ccl2), were confirmed by in vitro studies of mRNA and protein expression in small airway epithelial cells exposed to MWCNT as concordant with in vivo expression. This study identified that the novel computational model was sufficient to determine biological processes strongly associated with the pathology of lung inflammation and fibrosis and could identify potential toxicity signaling pathways and mechanisms of MWCNT exposure which could be used for future animal studies to support human risk assessment and intervention efforts.

[1]  P. Ajayan Nanotubes from Carbon. , 1999, Chemical reviews.

[2]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[3]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[4]  Tejal A Desai,et al.  Whole genome expression analysis reveals differential effects of TiO2 nanotubes on vascular cells. , 2010, Nano letters.

[5]  Ka Yee Yeung,et al.  Principal component analysis for clustering gene expression data , 2001, Bioinform..

[6]  R. Strieter,et al.  New mechanisms of pulmonary fibrosis. , 2009, Chest.

[7]  V. Castranova Overview of Current Toxicological Knowledge of Engineered Nanoparticles , 2011, Journal of occupational and environmental medicine.

[8]  Kyung Hee Hong,et al.  Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. , 2005, Blood.

[9]  Julian Dymacek,et al.  Systems Approach to Identifying Relevant Pathways from Phenotype Information in Dose-Dependent Time Series Microarray Data , 2011, 2011 IEEE International Conference on Bioinformatics and Biomedicine.

[10]  Yong Qian,et al.  Multiwalled Carbon Nanotube-Induced Gene Signatures in the Mouse Lung: Potential Predictive Value for Human Lung Cancer Risk and Prognosis , 2012, Journal of toxicology and environmental health. Part A.

[11]  Vincent Castranova,et al.  Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes , 2011, Particle and Fibre Toxicology.

[12]  A. Pant,et al.  Multi-walled carbon nanotubes induce oxidative stress and apoptosis in human lung cancer cell line-A549 , 2011, Nanotoxicology.

[13]  Liying Wang,et al.  Assessment of pulmonary fibrogenic potential of multiwalled carbon nanotubes in human lung cells , 2012 .

[14]  T. Wynn,et al.  Cellular and molecular mechanisms of fibrosis , 2008, The Journal of pathology.

[15]  F. Martinez,et al.  Mechanisms of pulmonary fibrosis. , 2004, Annual review of medicine.

[16]  J. Nagy,et al.  Respiratory toxicity of multi-wall carbon nanotubes. , 2005, Toxicology and applied pharmacology.

[17]  Vincent Castranova,et al.  Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes , 2010, Particle and Fibre Toxicology.

[18]  R G Ulrich,et al.  Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. , 2001, Toxicology letters.

[19]  Qi-qing Zhang,et al.  ROS and NF-kappaB are involved in upregulation of IL-8 in A549 cells exposed to multi-walled carbon nanotubes. , 2009, Biochemical and biophysical research communications.

[20]  Vandana Saini,et al.  MCP-1: chemoattractant with a role beyond immunity: a review. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[21]  T. Laoui,et al.  Spark plasma sintering of metals and metal matrix nanocomposites: a review , 2012 .

[22]  R. Brentani,et al.  Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections , 1979, The Histochemical Journal.

[23]  X. He,et al.  Multiwalled carbon nanotubes induce a fibrogenic response by stimulating reactive oxygen species production, activating NF-κB signaling, and promoting fibroblast-to-myofibroblast transformation. , 2011, Chemical research in toxicology.

[24]  E. Miyazaki,et al.  Significance of Serum Vascular Endothelial Growth Factor Level in Patients with Idiopathic Pulmonary Fibrosis , 2010, Lung.

[25]  Nianqiang Wu,et al.  Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. , 2010, Toxicology.

[26]  V. Castranova,et al.  Cell Permeability, Migration, and Reactive Oxygen Species Induced by Multiwalled Carbon Nanotubes in Human Microvascular Endothelial Cells , 2012, Journal of toxicology and environmental health. Part A.

[27]  Diane Schwegler-Berry,et al.  Potential in vitro effects of carbon nanotubes on human aortic endothelial cells. , 2009, Toxicology and applied pharmacology.

[28]  J. Mesirov,et al.  Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Vincent Castranova,et al.  A biocompatible medium for nanoparticle dispersion , 2008 .

[30]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  I. Stiharu,et al.  Identification of deregulated genes by single wall carbon-nanotubes in human normal bronchial epithelial cells. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[32]  S. Iijima Helical microtubules of graphitic carbon , 1991, Nature.

[33]  D. Warburton,et al.  Development, repair and fibrosis: What is common and why it matters , 2009, Respirology.

[34]  Lyle D Burgoon,et al.  Automated quantitative dose-response modeling and point of departure determination for large toxicogenomic and high-throughput screening data sets. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  E. Weibel Stereological Methods. Practical methods for biological morphometry , 1979 .

[36]  Harvey J Clewell,et al.  A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  Yong Qian,et al.  Multi-walled carbon nanotube-induced gene expression in the mouse lung: association with lung pathology. , 2011, Toxicology and applied pharmacology.

[38]  R. Strieter What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis. , 2008, Proceedings of the American Thoracic Society.

[39]  Heidrun Ellinger-Ziegelbauer,et al.  Pulmonary toxicity of multi-walled carbon nanotubes (Baytubes) relative to alpha-quartz following a single 6h inhalation exposure of rats and a 3 months post-exposure period. , 2009, Toxicology.

[40]  S. Sung,et al.  Significant Involvement of CCL2 (MCP‐1) in Inflammatory Disorders of the Lung , 2003, Microcirculation.